Results 131 to 140 of about 852,629 (213)

Upadacitinib-Induced Remission in Multicentric Reticulohistiocytosis: Expanding the Therapeutic Role of JAK Inhibition. [PDF]

Int J Mol Sci
Pamfil C, Taki MA, Candrea E, Damian L, Mihon MI, Moldovan DMM, Rednic S.   +6 more
europepmc   +1 more source

Short-term omalizumab as a potential rescue therapy for alopecia areata flares during Janus kinase inhibitor maintenance. [PDF]

JAAD Int
Wang Q, Cheng K, Lin JM, Tao K, Xu M, Zhang X, Tang S, Ni C, Wu W, Lin J.   +9 more
europepmc   +1 more source

JAK inhibitors in livedoid vasculopathy associated with thrombophilia and refractory to anticoagulation: report and literature review. [PDF]

An Bras Dermatol
Criado GJ, Criado PR, Lorenzini D, Miot HA.   +3 more
europepmc   +1 more source

ODF3B Promotes the Progression of Clear Cell Renal Cell Carcinoma via the JAK/STAT Signaling Pathway. [PDF]

Med Sci Monit
Yun Y, Ji X, Wu T, Liu Y, Li Z, Sun Z, Zhou P, Yang L, Yu W.   +8 more
europepmc   +1 more source

OpenGrey - jak funguje a jak se používá

, 2011
OpenGrey is a unique repository providing open access to European grey literature references, the result of 25 years of cooperation. This paper presents the features of the new website, successor to OpenSIGLE, and reports on lessons learned from the transfer of metadata between platforms.
openaire   +1 more source

Genetic pharmacoepidemiology of JAK inhibitors in chronic immune-mediated skin diseases: implications for precision therapy and medication safety. [PDF]

Front Pharmacol
Zhang Y, Qu Y, Luo Q, Liang B, Jiang Q, Zhu X, Wu J, Bao W.   +7 more
europepmc   +1 more source

Recombinant zoster vaccine in patients with inflammatory rheumatic diseases: efficacy, long-term protection and safety under immunosuppression. [PDF]

RMD Open
Krasselt M.
europepmc   +1 more source

Upadacitinib in rheumatoid arthritis: progress and challenges. [PDF]

Front Pharmacol
Wang Q, Zhong L, Fu Y, Yang Z.
europepmc   +1 more source

Alopecia Areata and Atopic Dermatitis: Common Mechanisms and Emerging Therapeutics. [PDF]

J Inflamm Res
Tang A, Rachko G, Manzo Margiotta F, Levine J, Del Duca E, Ungar B.   +5 more
europepmc   +1 more source